help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cai, A.
Right arrow Articles by Hyde, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cai, A.
Right arrow Articles by Hyde, J. F.
Endocrinology Vol. 140, No. 11 4955-4964
Copyright © 1999 by The Endocrine Society

ARTICLES

Targeted Overexpression of Galanin in Lactotrophs of Transgenic Mice Induces Hyperprolactinemia and Pituitary Hyperplasia1

Aihua Cai, J. David Hayes, Nihar Patel and James F. Hyde

Department of Anatomy and Neurobiology, University of Kentucky College of Medicine, Lexington, Kentucky 40536

Address all correspondence and requests for reprints to: James F. Hyde, Ph.D., Department of Anatomy and Neurobiology, University of Kentucky College of Medicine, 800 Rose Street (MN224), Lexington, Kentucky 40536-0084. E-mail: jfhyde00{at}pop.uky.edu

We generated transgenic mice that carry 4.6 kb of the mouse galanin gene fused to 2.5 kb of the rat PRL promoter. In all transgenic lines that carried and transmitted the transgene, there were significant increases in galanin messenger RNA and peptide levels in the anterior pituitary in both male and female transgenic mice, and the elevation of galanin was restricted to the anterior lobe. Furthermore, galanin release from pituitary cells in vitro of both male and female transgenic mice was dramatically increased compared with that in control mice. At 2–4 months of age, pituitary PRL contents in female transgenic mice were increased compared with those in normal controls. Moreover, PRL messenger RNA levels were increased in female transgenic mice. However, plasma levels of PRL in female transgenic mice were not significantly higher until 6 months of age. By 11 months of age, cell numbers in the anterior pituitary were increased in female, but not male, transgenic mice. The percentage of lactotrophs in female transgenic mice as well as PRL gene expression per cell were significantly higher. No differences were detected in PRL content, gene expression, or release between normal and transgenic male mice. Six weeks of estrogen treatment significantly increased anterior pituitary weights and PRL secretion in male transgenic mice compared with that in normal male mice. In addition, anterior pituitary weights and PRL secretion were decreased in female transgenic mice compared with controls 6 weeks after ovariectomy. We conclude that overexpression of galanin in lactotrophs stimulates PRL synthesis and secretion and acts as a growth factor resulting in the formation of pituitary hyperplasia and hyperprolactinemia. Furthermore, estrogen appears critical for these galanin-mediated events.




This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
M. P. Gillam, M. E. Molitch, G. Lombardi, and A. Colao
Advances in the Treatment of Prolactinomas
Endocr. Rev., August 1, 2006; 27(5): 485 - 534.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. J. Naylor, E. Ginsburg, T. P. Iismaa, B. K. Vonderhaar, D. Wynick, and C. J. Ormandy
The Neuropeptide Galanin Augments Lobuloalveolar Development
J. Biol. Chem., August 1, 2003; 278(31): 29145 - 29152.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Y. Q. Wang, R. Yuan, Y.-P. Sun, T.-J. Lee, and G. V. Shah
Antiproliferative Action of Calcitonin on Lactotrophs of the Rat Anterior Pituitary Gland: Evidence for the Involvement of Transforming Growth Factor {beta}1 in Calcitonin Action
Endocrinology, May 1, 2003; 144(5): 2164 - 2171.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. T. Hentges and M. J. Low
Ovarian Dependence for Pituitary Tumorigenesis in D2 Dopamine Receptor-Deficient Mice
Endocrinology, December 1, 2002; 143(12): 4536 - 4543.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. S. Moons, S. Jirawatnotai, A. F. Parlow, G. Gibori, R. D. Kineman, and H. Kiyokawa
Pituitary Hypoplasia and Lactotroph Dysfunction in Mice Deficient for Cyclin-Dependent Kinase-4
Endocrinology, August 1, 2002; 143(8): 3001 - 3008.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Spada and P. Beck-Peccoz
Editorial: New Strategy to Solve the Etiopathogenetic Conundrum of Pituitary Adenomas
Endocrinology, February 1, 2002; 143(2): 343 - 346.
[Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Schwartz
Intercellular Communication in the Anterior Pituitary
Endocr. Rev., October 1, 2000; 21(5): 488 - 513.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society